- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Cassling Diagnostic makes management moves
Medical imaging equipment refurbisher Cassling Diagnostic Imaging shifted its management structure this month when it appointed three new executives to posts within its organization and that of its subsidiary, Integrated Equipment Solutions. The Omaha,
Medical imaging equipment refurbisher Cassling Diagnostic Imaging shifted its management structure this month when it appointed three new executives to posts within its organization and that of its subsidiary, Integrated Equipment Solutions. The Omaha, NE, firm named Merl Dunham technical director of its imaging information and integration division. Dunham will manage CDIs integration lab and personnel and will provide technical support and integration coordination. He will report to Marty Huebner, vice president of service. CDI also appointed Randy Wobig to the post of clinical network specialist. Wobig will oversee CDIs networking department. Finally, CDIs subsidiary, Integrated Equipment Solutions, named Dale Ray vice president of sales and marketing. Ray has served as field manager for Philips Medical, vice president of sales and marketing for Fischer Imaging, and has held various management positions with Marconi Medical Systems. He will report to Gary Nie, vice president of integrated services, and will develop the companys worldwide sales force.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
